Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back

Ana-Maria Orbai, MD, MHS

Johns Hopkins University School of Medicine, Division of Rheumatology
Baltimore, MD, United States

Ana-Maria Orbai, M.D., M.H.S., is Associate Professor of Medicine in the Division of Rheumatology at the Johns Hopkins University School of Medicine, and founding director of the Psoriatic Arthritis Program.
Dr. Orbai earned her M.D. from the Iuliu Hatieganu School of Medicine and Pharmacy, Cluj-Napoca, in Romania. She completed internship and residency training in internal medicine at the Johns Hopkins University-Sinai Hospital program. Subsequently, Dr. Orbai completed her post-doctoral fellowship training in rheumatology at Johns Hopkins. During her fellowship she earned her Master in Health Sciences degree in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health.
Dr. Orbai's research focus is characterization of psoriatic disease phenotypes and individualizing treatment strategies, with the goal to improve long-term patient outcomes.

Presentation(s):

  • 319: Measures Of Healthcare Quality Poster Tour

    Monday, November 13, 2023
    10:15 AM – 11:00 AM PT

    Disclosure(s): AbbVie/Abbott: Grant/Research Support (Ongoing); Amgen: Grant/Research Support (Terminated); Bristol-Myers Squibb(BMS): Consultant (Terminated); Celgene: Grant/Research Support (Terminated); Eli Lilly: Consultant (Terminated), Grant/Research Support (Terminated); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Terminated), Grant/Research Support (Terminated); Pfizer: Consultant (Terminated)

  • 237: Raising the Bar: Optimizing Outcomes With IL-23/IL-17 Inhibitors in Spondyloarthritis

    Tuesday, November 14, 2023
    6:00 PM – 8:00 PM PT

    Disclosure(s): AbbVie/Abbott: Grant/Research Support (Ongoing); Amgen: Grant/Research Support (Terminated); Bristol-Myers Squibb(BMS): Consultant (Terminated); Celgene: Grant/Research Support (Terminated); Eli Lilly: Consultant (Terminated), Grant/Research Support (Terminated); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Terminated), Grant/Research Support (Terminated); Pfizer: Consultant (Terminated)